Angiotensin converting enzyme inhibitors and progression of chronic renal failure

Jonathan P. Tolins, Leopoldo Raij

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Renal failure, once established by loss of a critical amount of functional renal mass, tends to be progressive. A large body of experimental evidence supports the hypothesis that glomerular capillary hypertension is important in the pathogenesis of progressive chronic renal failure of diverse types, including subtotal renal ablation and diabetic nephropathy. Converting enzyme inhibitors are effective in slowing or arresting the progression of glomerular injury in these experimental models, in association with normalization of both systemic and intrarenal pressures. Clinical studies of diabetic nephropathy and chronic renal failure of other etiologies support the concept that these same renal hemodynamic factors are important in human renal disease and that treatment with converting enzyme inhibitors may prove to be a useful therapeutic intervention. Whether the converting enzyme inhibitors have specific advantages over other antihypertensive agents due to beneficial renal hemodynamic effects, as suggested by experimental studies, is a question that awaits further investigation. Furthermore, the pathogenesis of hypertensive glomerular injury is complex and involves the participation of diverse biologic systems. We predict that a wide variety of therapeutic maneuvers, with disparate mechanisms of action, may be effective in arresting or preventing glomerular injury.

Original languageEnglish
JournalKidney International
Volume38
Issue numberSUPPL. 30
StatePublished - Nov 1 1990
Externally publishedYes

Fingerprint

Angiotensin-Converting Enzyme Inhibitors
Chronic Kidney Failure
Kidney
Enzyme Inhibitors
Diabetic Nephropathies
Wounds and Injuries
Hemodynamics
Antihypertensive Agents
Renal Insufficiency
Theoretical Models
Hypertension
Pressure
Therapeutics

ASJC Scopus subject areas

  • Nephrology

Cite this

Angiotensin converting enzyme inhibitors and progression of chronic renal failure. / Tolins, Jonathan P.; Raij, Leopoldo.

In: Kidney International, Vol. 38, No. SUPPL. 30, 01.11.1990.

Research output: Contribution to journalArticle

Tolins, Jonathan P. ; Raij, Leopoldo. / Angiotensin converting enzyme inhibitors and progression of chronic renal failure. In: Kidney International. 1990 ; Vol. 38, No. SUPPL. 30.
@article{7f13218a2046460fbb693ea930c93e1e,
title = "Angiotensin converting enzyme inhibitors and progression of chronic renal failure",
abstract = "Renal failure, once established by loss of a critical amount of functional renal mass, tends to be progressive. A large body of experimental evidence supports the hypothesis that glomerular capillary hypertension is important in the pathogenesis of progressive chronic renal failure of diverse types, including subtotal renal ablation and diabetic nephropathy. Converting enzyme inhibitors are effective in slowing or arresting the progression of glomerular injury in these experimental models, in association with normalization of both systemic and intrarenal pressures. Clinical studies of diabetic nephropathy and chronic renal failure of other etiologies support the concept that these same renal hemodynamic factors are important in human renal disease and that treatment with converting enzyme inhibitors may prove to be a useful therapeutic intervention. Whether the converting enzyme inhibitors have specific advantages over other antihypertensive agents due to beneficial renal hemodynamic effects, as suggested by experimental studies, is a question that awaits further investigation. Furthermore, the pathogenesis of hypertensive glomerular injury is complex and involves the participation of diverse biologic systems. We predict that a wide variety of therapeutic maneuvers, with disparate mechanisms of action, may be effective in arresting or preventing glomerular injury.",
author = "Tolins, {Jonathan P.} and Leopoldo Raij",
year = "1990",
month = "11",
day = "1",
language = "English",
volume = "38",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "SUPPL. 30",

}

TY - JOUR

T1 - Angiotensin converting enzyme inhibitors and progression of chronic renal failure

AU - Tolins, Jonathan P.

AU - Raij, Leopoldo

PY - 1990/11/1

Y1 - 1990/11/1

N2 - Renal failure, once established by loss of a critical amount of functional renal mass, tends to be progressive. A large body of experimental evidence supports the hypothesis that glomerular capillary hypertension is important in the pathogenesis of progressive chronic renal failure of diverse types, including subtotal renal ablation and diabetic nephropathy. Converting enzyme inhibitors are effective in slowing or arresting the progression of glomerular injury in these experimental models, in association with normalization of both systemic and intrarenal pressures. Clinical studies of diabetic nephropathy and chronic renal failure of other etiologies support the concept that these same renal hemodynamic factors are important in human renal disease and that treatment with converting enzyme inhibitors may prove to be a useful therapeutic intervention. Whether the converting enzyme inhibitors have specific advantages over other antihypertensive agents due to beneficial renal hemodynamic effects, as suggested by experimental studies, is a question that awaits further investigation. Furthermore, the pathogenesis of hypertensive glomerular injury is complex and involves the participation of diverse biologic systems. We predict that a wide variety of therapeutic maneuvers, with disparate mechanisms of action, may be effective in arresting or preventing glomerular injury.

AB - Renal failure, once established by loss of a critical amount of functional renal mass, tends to be progressive. A large body of experimental evidence supports the hypothesis that glomerular capillary hypertension is important in the pathogenesis of progressive chronic renal failure of diverse types, including subtotal renal ablation and diabetic nephropathy. Converting enzyme inhibitors are effective in slowing or arresting the progression of glomerular injury in these experimental models, in association with normalization of both systemic and intrarenal pressures. Clinical studies of diabetic nephropathy and chronic renal failure of other etiologies support the concept that these same renal hemodynamic factors are important in human renal disease and that treatment with converting enzyme inhibitors may prove to be a useful therapeutic intervention. Whether the converting enzyme inhibitors have specific advantages over other antihypertensive agents due to beneficial renal hemodynamic effects, as suggested by experimental studies, is a question that awaits further investigation. Furthermore, the pathogenesis of hypertensive glomerular injury is complex and involves the participation of diverse biologic systems. We predict that a wide variety of therapeutic maneuvers, with disparate mechanisms of action, may be effective in arresting or preventing glomerular injury.

UR - http://www.scopus.com/inward/record.url?scp=0025149392&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025149392&partnerID=8YFLogxK

M3 - Article

C2 - 2259070

AN - SCOPUS:0025149392

VL - 38

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - SUPPL. 30

ER -